for the remainder of the infection to kill all extracellular, but not intracellular bacteria (6) . 125
We observed that the V. para. CAB2 containing a functional T2SS2 can efficiently 126 invade, replicate (indicated by the increase in CFU counts), and escape from the host 127 cell (indicated by the after-peak decrease in CFU counts due to exposure of egressed 128 bacteria to gentamicin) (Figure 1A, black bars) . By contrast, a CAB2 strain deleted for 129 vpa0226 (CAB2Δvpa0226) results in cells that have increasing amounts of bacteria with 130 no significant decrease for up to 7 hours post gentamicin treatment (PGT), indicating 131 the inability of these bacteria to escape from an invaded cell (Figure 1A, green bars) . 132
133
To test whether cell egress was attributed to VPA0226's catalytic activity, we 134 complemented the CAB2Δvpa0226 with a wildtype copy of VPA0226 135 (CAB2Δvpa0226+WT) or with a catalytically inactive copy of VPA0226 136 (CAB2Δvpa0226+S/A). While in-trans complementation with a wildtype copy of 137 VPA0226 allowed for bacterial escape, the catalytically inactive form of VPA0226 did 138 not allow for egress of V. para from the host cell. (Figure 1B) . Furthermore, the 139 decrease in number of lysed host cells, as well as the decreased number of egressed 140 mutant bacteria at 7 hours PGT in comparison to its parental strain is consistent with 141 these findings (Figure 1-figure supplement 1C and D, respectively) . We next turned 142 to confocal microscopy and observed over the course of an infection (1, 3, 7 hours) that 143 all CAB2 strains escape from the endocytic vacuole and replicate in the cytoplasm 144 (Figure 1-figure supplement 1E and F) . However, only CAB2 and 145
CAB2Δvpa0226+WT, but not CAB2Δvpa0226 and CAB2Δvpa0226+S/A, escape from 146 the host cell after 7 hours PGT ( Figure 1C and Figure 1-figure supplement 1F) . 147
These results support the previous observation that, in the absence of VPA0226, 148 bacteria are unable to egress from its host cell. 149 150 VPA0226 is secreted by the type 2 secretion system 151
We speculated that VPA0226 is translocated as a T3SS effector, as it appears that 152 VPA0226 is essential for V. para's egress from the host cell when the bacterium uses a 153 T3SS2-dependent mechanism to invade such cell (4). To test this hypothesis, we 154 followed the secretion of VPA0226 from various V. para strains, including CAB2, CAB2Δvpa0226, CAB3 (a strain that only contains the T3SS1), and CAB4 (a strain that 156 contains neither T3SS1 nor T3SS2). To our surprise, with the exception of the 157 CAB2Δvpa0226 strain, we observed VPA0226 to be constitutively secreted from all of 158 these V. para strains (Figure 1-figure supplement 2A) . Further bioinformatic analysis 159 using SignalP5.0 revealed that VPA0226 contained a signal peptide at its N-terminus 160 similar to those found for enzymes that are secreted out of the type 2 secretion system 161 (15) (Figure 1-figure supplement 2B) . To test whether VPA0226 is secreted through 162 this system, we assayed the following strains for VPA0226 secretion: CAB2; 163
CAB2Δvpa0226; a CAB2 strain deleted for EpsD (an essential type 2 secretion system 164 outer membrane component), CAB2ΔepsD; and the EpsD complemented strain 165
CAB2ΔepsD+EpsD. We observed that VPA0226 is secreted by CAB2 and 166
CAB2ΔepsD+EpsD, but not by CAB2Δvpa0226 or CAB2ΔepsD, thereby demonstrating 167 that VPA0226 is secreted by the type 2 secretion system (Figure 1D, Figure 1-figure  168 supplement 2C). 169 170
Intracellular VPA0226 associates with and disrupts membranes of invaded cells. 171
Since VPA0226 is predicted to be a lipase that hydrolyses fatty acids of phospholipids 172 and can transfer fatty acids to cholesterol, we speculated that VPA0226 would be 173 associated with a host membrane. We expected VPA0226 would associate with the 174 plasma membrane as it appears to be involved in bacterial egress from the host cell 175 through this membrane. To test this hypothesis, we transiently transfected VPA0226 176 tagged with GFP (VPA0226-GFP) into HeLA cells and observed that cells expressing 177 VPA0226-GFP died within 24 hours (data not shown); however, at an earlier time point 178 (14 hours), the transfected cells were viable. Somewhat perplexing, VPA0226-GFP 179 was not localized to the plasma membrane but to an intracellular membrane 180 compartment (Figure 2A) . To assess which compartment this might be, we co-stained 181 transfected cells with markers for a number of intracellular compartments, including 182 early endosomes using EEA1, late endosomes/lysosomes using Lamp-1, endoplasmic 183 reticulum using calnexin and mitochondria using Acetyl-CoA acetyl transferase (ACAT1) 184 and COXIV (Figure 2, Figure 2-figure supplement 1A,B,C,D) . The only markers co-185 staining with VPA0226 were ACAT1 and COXIV, indicating that VPA0226 associates with the mitochondria (Figure 2A, figure 2-figure supplement 1D ). In addition, while 187 mitochondria of cells mock-transfected or transfected with the catalytically inactive 188 VPA0226 (VPA0226-H/A) show normal cell morphology, cells transfected with the 189 wildtype VPA0226 display fragmented mitochondria (Figure 2A, figure 2 
V. para-initiated apoptosis is not required for bacterial cell egress 206
Based on these studies, we made the supposition that disrupting lipids in the 207 mitochondrial membrane causes fragmentation of this membrane and compromises the 208 integrity of this compartment resulting in cytochrome C release and the initiation of 209 apoptosis. However, the initiation of these events would not support a mechanism for 210 egress of V. para from the host cell as apoptosis does not result in lysis or release of 211 intracellular contents. Instead, if VPA0226 would compromise the cellular membranes 212 by esterifying cholesterol, the integrity of all membranes would be compromised, 213
including the plasma membrane, thereby allowing the escape of V. para. from host 214
cells. 215
To address these hypotheses, we analyzed apoptotic signaling in host cells during 217 infection. Since mitochondria are fragmented at 2 hours PGT, we tested whether 218 Cytochrome C, an initiator of apoptosis, is released from the mitochondria at some point 219 after this. Consistent with this idea, we observed the release of Cytochrome C into the 220 cytoplasm in CAB2 and CAB2Δvpa0226+WT infected cells, but not CAB2Δvpa0226 and 221
CAB2Δvpa0226+S/A infected cells (Figure 2-figure supplement 2A To address how VPA0226-mediated fragmentation of the mitochondria was occurring, 239
we analyzed the lipase activity of VPA0226 and its impact on host cellular lipids during 240 the course of infection. Previously, it was shown that lipases similar to VPA0226 can 241 esterify cholesterol by the transfer of an acyl group from an acyl-containing lipid to 242 cholesterol thereby converting free cholesterol to a cholesteryl ester (16, 17) . It should 243 be noted that only the lipase activity, but not the transferase activity, has been observed 244 previously for Vibrio lipases (14,18). To confirm lipase activity of VPA0226, we tested 245 this enzyme with the EnzChek® Phospholipase A2 (PLA2) Assay Kit (Invitrogen). 246
Purified wildtype VPA0226 but not the catalytically inactive VPA0226-S/A mutant resulted in a concentration dependent increase in fluorescence from a PLA2 specific 248 fluorogenic substrate (BODIPY PC-A2) (Figure 3-figure supplement 1A) . We next 249 assessed whether VPA0226 can directly modify cholesterol by incubating purified 250 secreted wildtype or catalytically dead VPA0226-S/A with liposomes containing lipid 251 mixtures of cardiolipin and cholesterol, followed by lipid extraction and thin layer 252 chromatography. We observed that the wildtype but not the catalytically inactive 
membrane. 285
We speculated that the dramatic increase in esterified cholesterol that correlated with 286 the fragmented mitochondrial membranes would compromise the integrity of all cellular 287 membranes, including the plasma membrane. To assess whether there was a decrease 288
in free cholesterol, we tested whether the cellular sensor for free cholesterol, SREBP, 289 was activated in cells transfected with VPA0226 (23). HeLa cells were transfected for 14 290 hours with empty vector, VPA0226 or the catalytically inactive VPA0226H/A and qPCR 291 analysis was performed assessing genes that are targets of SREBP transcriptional 292 activity. We observed all three genes, HMGCR, HMGCS and DHCR24, were 293 upregulated in cells expressing VPA0226, but not in cells with the empty vector or the 294 catalytically inactive VPA0226H/A ( Figure 4A) . These data support the proposal that 295 cholesterol levels are being compromised in cells expressing VPA0226. 296 297 Next, we asked whether cells subjected to VPA0226 activity might be more fragile when 298 subjected to mechanical stress, in this case we used osmotic stress. HeLa cells were 299 transfected for 14 hours with empty vector, VPA0226 or the catalytically inactive 300 VPA0226-H/A and then treated with water containing propidium iodide to assess their 301 susceptibility to hypotonic stress. We observed that cells expressing VPA0226, but not 302 in cells with the empty vector or the catalytically inactive VPA0226-H/A, lysed more 303 readily as indicated by an increase in fluorescence ( Figure 4B) . 304 305 Finally, to further assess the integrity of the plasma membrane during infection, HeLa 306 cells were infected with CAB2 strains and tested for permeability using Sytox, a stain 307 that is only permeable to damaged membranes. We observe that cells infected with 308 either CAB2 or CAB2Δvpa0226+WT, but not with CAB2Δvpa0226 and CAB2Δvpa0226+S/A, take up the Sytox stain at 5 hours PGT, indicating that their 310 membranes have been compromised ( Figure 4C) . Furthermore, only cells that are 311 invaded with V. para take up the sytox stain, consistent with the observation that only 312 the invaded cells with an internal source of VPA0226 have compromised membranes. 313 314 315
Discussion 316
Intracellular bacteria must find mechanisms to invade, survive and escape the host cell. 317
Previously, the mechanism of entry for V. para was discovered to be mediated by the 318 deamidase activity of VopC (4). Further studies uncovered mechanisms used by V. para 319 to attenuate signaling pathways inside the infected cell, by effectors such as VopA and 320
VopL (3, 9) . Many other mechanisms remain to be elucidated for V. para's defense 321 against the host. Herein, we find that the escape route for V. para mediated host cell 322 invasion is dependent on the Type 2 secreted lipase VPA0226 that compromises the 323 integrity of the plasma membrane by using polyunsaturated fatty acids to esterify 324 cholesterol in the infected cell. For this pathogen, VPA0226 provides an essential 325 activity for the virulence of the T3SS2 pathogenicity island by providing a convenient 326 mechanism for escape. When dissecting the activity mediated by VPA0226, we are 327 struck by its many unconventional and somewhat perplexing properties, including its 328 secretion, enzymology and biology. 329 330 VPA0226 is secreted, not by the T3SS2, but by the type 2 secretion system. These 331 findings make it very clear that, although we attribute V. para virulence to T3SS2, this 332 bacterial pathogen uses many tools outside of this pathogenicity island for a successful 333 infection. Other tools would include external host signaling factors, such as bile salts for 334 activation of the system and adhesion proteins used to attach to host cells (24,25). 335 336 VPA0226 appears to be constitutively secreted from V. para by the type 2 secretion 337 system, as we saw no accumulation of VPA0226 inside V. para cells, indicating that, as 338 it is synthesized it is secreted (Figure1 -Figure supplement-2) . Additionally, when 339 media is collected from log-phase V. para cultures, we are able to purify VPA0226 from the culture medium. We propose that VPA0226 is constitutively secreted by intracellular 341 bacteria during infection because we only observe changes in the mitochondria, release 342 of cytochrome C, TUNEL positive cells and sytox membrane permeability in host cells 343 that are invaded with V. para expressing wild type VPA0226. Therefore, VPA0226 344 targets host cell machinery from within the host cell and not from the outside. shown to induce NF-κB-dependent mitochondrial cell death mediated by the production 362 of lipid raft-dependent ROS (31). Another structural homologue lec / VC_A0218 in V. 363 cholerae with lipase activity is implicated in escape from the infected amoeba (18). In 364 addition, a genetically non-homologous but functionally similar TgLCAT, lecithin: 365 cholesterol acyltransferase encoded by a protozoan parasite Toxoplasma gondii is also 366 implicated in host cell egress (32). 367
368
Using bioinformatics and clustering analysis, we find that VPA0226 is in a clan of 369 enzymes containing invariant catalytic Ser, Gly, Asn and His residues which are 370 referred to as GDSL-like lipases (33) (Figure 1-figure supplement 1C) . VPA0226 and homologs from other Vibrio species, together with the Salmonella phospholipase 372 effector SseJ, are located in a mostly bacterial subfamily, closely related to plant and 373 fungal GDSL lipases and only remotely related to animal GDSL lipases, e.g. human 374
Phospholipase B1 (Figure 3-figure supplement 1D) . Based on this conservation, we 375 predict that the presence of VPA0226 in the V. para genome predated the acquisition of 376 the T3SS2 pathogenicity island (2). From an evolutionary standpoint, it is interesting 377 (and resourceful on the part of a bacterial pathogen) that this enzyme subsequently 378 became an essential factor for escape of the invading V. para.. Interestingly, the 379 bacterial-plant-fungal GDSL lipase subfamily includes a large plant group of 380 extracellular lipases (e.g. more than 100 different proteins in Arabidopsis), many of 381 which are involved in regulation of defense against bacterial and fungal pathogens. mechanical stress, egresses from the host cell. We observe that V. para uniquely 409 utilizes two independent secretion systems to support its intracellular lifestyle. From the 410 perspective of virulence, V. para appears to have utilized existing resources to evolve 411 an efficient mechanism for invasion, propagation and escape. We speculate, 412
considering the time pathogens have to evolve, that there is actually more interplay 413 between secretion systems, providing unique, synergistic mechanisms to support a 414 successful lifestyle of possibly pathogenicity, symbiosis and/or parasitosis. 415 416
Materials and Methods 417
Bacterial strains and culture conditions 418
The V. parahaemolyticus CAB2 strain was derived from POR1 (clinical isolate 419 RIMD2210633 lacking TDH toxins), the latter being a generous gift from Drs. Tetsuya 420
Iida and Takeshi Honda (4,37). The CAB2 strain was made by deleting the gene 421 encoding the transcriptional factor ExsA, which regulates the activation of the T3SS1 422 (4,38). CAB2 was grown in Luria-Bertani (LB) medium, supplemented with NaCl to a 423 final concentration of 3% (w/v), at 30 °C. When necessary, the medium was 424 supplemented with 50 μg/mL spectinomycin (to select for growth of CAB2-GFP 425 strains(39)) or 250 μg/mL kanamycin. HeLa cells were seeded onto 6-well plates containing sterile coverslips at a density of 524 7x10 4 cell/mL. Following infections with V. para. strains and indicated gentamicin treatment times, cells were washed with PBS and fixed in 3.2% (v/v) para-formaldehyde 526 for 10 min at room temperature. Fixed cells were washed in PBS and permeabilized 527 with either 0.5% Triton X-100 in PBS (EEA1) or 0.5% saponin in PBS (LAMP1) for 4 528 min at room temperature(6). For calnexin, ACAT1, COXIV and Cyto C, fixed cells were 529 permeabilized with ice cold methanol for 10 min at -20 o C. After washing with PBS, 530 blocking was performed with either 1% BSA (EEA1), 1%BSA with 0.1% saponin 531 (LAMP1) or 5% normal goat serum with 0.3% Triton X-100 (calnexin, ACAT1, COXIV 532 and Cyto C) for 30 minutes at room temperature. Primary and secondary antibodies 533 were diluted in PBS containing either 0.5% BSA and 0.25% Tween 20 (EEA1), 0.5% 534 BSA and 0.25% saponin (LAMP1) or 1% BSA and 0.3% Triton X-100 at appropriate 535 dilutions and incubated serially for 1h at room temperature. Between each antibody 536 incubation, coverslips were washed three times with PBS or PBS containing 0.1% 537 saponin (LAMP1) for 5 min each wash. Nuclei and actin cytoskeleton were stained with 538
Hoechst (Sigma) and rhodamine-phalloidin (Molecular Probes), respectively. For Sytox 539 orange (Thermo Fisher Scientific) staining, cells were incubated with 0.5 µM Sytox 540 orange for 15 min following infections with V. para. strains and gentamicin treatment. 541 TUNEL staining was performed using DeadEnd fluorometric TUNEL system (Promega) 542 according to manufacturer's instructions. Briefly, HeLa cells following infections and 543 gentamicin treatment were fixed with 3.2% paraformaldehyde for 10 min at room 544 temperature and permeabilized using 0.2% triton x 100 in PBS for 5 min at room 545 temperature. Cells were then incubated with equilibration buffer for 10 min at room 546 temperature followed by incubation with rTdT nucleotide mix at 37 o C for 1h and nuclear 547 staining with Hoechst. All imaging was performed on a Zeiss LSM 800 confocal 548 microscope and images were converted using ImageJ (NIH). 549 550
Mammalian expression constructs + transfection 551
For mammalian cell expression, full length VPA0226 was amplified using primers 3' 552 GATC AGATCT ATGATGAAAAAAACAATCACACTA 5' and 5' GATA GAATTC G 553 GAAACGGTACTCGGCTAAGTTGTT 3' and cloned in frame with GFP into the 554 expression vector sfGFP-N1 (41) (Addgene) between BglII and EcoRI sites for the 555 expression of C terminally tagged VPA0226. Generating a catalytically inactive S153A for this construct however, did not result in successful mammalian cell expression 557 through transfection. Therefore, a second catalytically inactive C terminally tagged 558 VPA0226 construct was then generated by subjecting the full-length plasmid to site 559 directed mutagenesis to change a single amino acid residue histidine at 393 position to For lipidomics analysis, transfections were carried out following a previously described 571 protocol (17). HeLa cells (3x10 6 ) were plated and transfected with 2 µg of plasmids 572 encoding VPA0226-WT sf-GFPN1 or VPA0226-H/A sf-GFPN1 using Polyjet transfection 573 reagent according to manufacturer's instructions. 14h post transfection cells were 574 washed 3 times with PBS and lipids were extracted from cell pellets following Bligh and 575
Dyer's protocol using chloroform : methanol : 0.88% NaCl in 1:2:0.8 ratio (19). The 576 extracted lipids were dissolved in 15 µl of chloroform and processed for TLC analysis 577 using plastic backed silica gel 60F254 plates (Sigma) and a mobile phase system 578 containing petroleum ether: ethyl ether: acetic acid in 90:10:1 ratio. Lipid spots were 579 visualized by exposure to iodine vapor. Cholesterol, cardiolipin (1',3'-bis[1,2-dioleoyl-sn- Samples were transferred to glass tubes for liquid-liquid extraction (LLE) by modified 591
Bligh/Dyer (42); 1mL each of dichloromethane, methanol, and water were added to the 592 glass tube containing the sample. The mixture was vortexed and centrifuged at 2671×g 593 for 5 min, resulting in two distinct liquid phases. The organic phase was collected to a 594 fresh glass tube with a Pasteur pipette and dried under N 2 . Samples were 595 resuspendend in hexane. 596
Lipids were analyzed by LC-MS/MS using a SCIEX QTRAP 6500 + equipped with a 597
Shimadzu LC-30AD (Kyoto, Japan) HPLC system and a 150 × 2.1 mm, 5µm Supelco 598
Ascentis silica column (Bellefonte, PA, USA). Samples were injected at a flow rate of 599 0.3 ml/min at 2.5% solvent B (methyl tert-butyl ether) and 97.5% Solvent A (hexane). 600 Solvent B is increased to 5% during 3 minutes and then to 60% over 6 minutes. Solvent 601 B is decreased to 0% during 30 seconds while Solvent C (90:10 (v/v) Isopropanol-602 water) is set at 20% and increased to 40% during the following 11 minutes. Solvent C is 603 increased to 44% during 6 minutes and then to 60% during 50 seconds. The system 604 was held at 60% of solvent C during 1 minutes prior to re-equilibration at 2.5% of 605 solvent B for 5 minutes at a 1.2mL/min flow rate. Solvent D (95:5 (v/v) Acetonitrile-water 606 with 10mM Ammonium acetate) was infused post-column at 0.03ml/min. Column oven 607 temperature was set to 25°C. Data was acquired in positive and negative mode by 608 employing polarity switching during the analysis. Data were acquired using multiple 609 reaction monitoring (MRM) transition for the major, abundant lipid species from all lipid 610 classes. Electrospray ionization source parameters were, GS1 40, Cur 20, source 611 temperature 150 °C, declustering potential 60, and collision energy 25. GS1 and 2 were 612 zero-grade air while Cur and CAD gas was nitrogen. MRM transitions for cholesteryl 613 esters were analyzed using MultiQuant software (SCIEX). 614 615 VPA0226 protein purification 616
One 6mL culture each of CAB2∆vpa0226 transformed with pBAD 6His::VPA0226 and 617
CAB2∆vpa0226 transformed with pBAD 6His::VPA0226 S153A was grown shaking overnight at 30ºC. Overnight cultures were each used to inoculate 500mL MLB, which 619 was grown shaking at 30ºC for three hours to an OD600 = 0.85. Cultures were induced 620 in 0.1% arabinose 8-12 hours shaking at 30ºC. Inductions were pelleted by 621 centrifugation at 4ºC in a JA10 Beckman & Coulter and supernatant was collected. 622 6xHis-tagged VPA0226 and VPA0226 S153A were purified from the supernatant using 623 were prepared as described previously (43). Briefly, dried lipid films containing lipid 640 mixture were hydrated in 100 µL of 50 mM Tris, pH 7.4, 160 mM KCl by continuous 641 vortexing for 5 min and taken through 5 cycles of freeze-thawing in liquid nitrogen. The 642 resulting liposomes were extruded using an Avanti miniextruder and 100 nm 643 polycarbonate membranes to obtain uniform liposomes. 10 µL of above liposomes were 644 mixed with 5 µg of purified VPA0226 WT or S153A protein in 50 mM Tris, pH 7.4, 645
160mM KCl plus 1.4% fat free albumin and incubated at 37 o C for 1h (16). Reactions 646 were terminated by the addition of chloroform:methanol (2:1 v/v) and the lipids were 647 extracted by Bligh and Dyers method (19) and dissolved in 15 µL of chloroform for TLC and a mobile phase system containing petroleum ether: ethyl ether: acetic acid in 650 90:10:1 ratio. Lipid spots were visualized by exposure to iodine vapor. Cholesterol 651 oleate (Sigma) and above-mentioned lipids were spotted as standards on the TLC plate. 652 653 qPCR analysis 654
Hela cells were transfected with empty vector sf-GFPN1, VPA0226-WT sf-GFPN1 or VPA0226-H/A sf-GFPN1 as described above. 14h post transfection, RNA was isolated from the transfected cells using RNAeasy plus mini kit (Qiagen) according to the manufacturer's instructions. cDNA was generated using the qScript cDNA synthesis kit (Qunatabio). qPCR analysis for gene expression levels was carried out on a CFX384 Touch Real-Time PCR Detection System using PerfeCTa SYBR Green Supermix (Quantabio) and 500nM primers. The primers were designed based on the established database, Primer Bank, PCR primers for Gene Expression Detection and Quantification and were checked for efficiency (44). Relative gene expression level for the target genes was calculated by the ΔCq method with respect to transcript levels of the housekeeping gene GAPDH.
Propidium Iodide binding assay
Susceptibility of Hela cells to mechanical stress was assessed following the protocol Hela cells transfected with empty vector sf-GFPN1, VPA0226-WT sf-GFPN1 or VPA0226-H/A sf-GFPN1 for 14 h were harvested by scraping the cells into sterile PBS.
The cells were washed twice with PBS. 1x 10^5 cells were resuspended in water containing 5 µM propidium iodide (ThermoFisher Scientific) and incubated at room temperature for 10 min. Fluorescence was immediately measured using a Clariostar plus plate reader with excitation/emission wavelengths at 530/620 nm.
655

Statistical analysis and bioinformatics 656
All data are given as mean ± standard deviation from at least 3 independent 657 experiments unless stated otherwise. Each experiment was conducted in triplicate. 
